The Cigna Group (CI)
Health Care4 articles
Price chart
Why is CI moving today?
+1.2%CI is +1.2% today, inside the ordinary range for a session (under 3%). No stories about it reached the feed in the last 24 hours.
What this does not prove. A story on the same day is evidence of timing, not of cause: it explains a move only if it accounts for the size and the direction, and most single-stock moves carry a sector or index component too. Nothing here is a forecast.
Source: Yahoo Finance - quote as of 2 days ago
The Cigna Group (CI) overview
The Cigna Group is a major U.S. health-insurance and pharmacy-benefits company.
CI is a member of the S&P 500. It sits in the Health Care sector. That sector covers pharmaceutical, biotech, device and managed-care companies.
The Cigna Group trades on the NYSE under the ticker symbol CI. The most recent market data puts the share price at about $302.30. That is up 1.17% on the session. At that price the company is worth roughly $79.88B.
Over the past 52 weeks, CI has traded between $239.51 and $311.34. Shares change hands at a trailing price-to-earnings (P/E) ratio of about 12.5. The P/E ratio sets the share price against a year of earnings. A higher number means the market is paying more for each dollar the company earns. CI also pays a dividend. It yields around 2.06% at the current price.
Key statistics
Source: Yahoo Finance - quote as of 2 days ago
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Why investors watch CI
CI is one of the larger names in the Health Care sector, so investors follow it closely. It tends to move with the rest of the sector. This page sums up each CI story as it breaks, and tags it bullish, bearish or neutral.
What moves CI
- Earnings. CI reports results four times a year. A surprise against the estimate tends to move the stock that day.
- Analyst calls. Upgrades, downgrades and new price targets change what the market expects from CI.
- Sector news. Health Care stocks often move together, so a rival's news can move CI too.
Market Mood
Latest CI news
Cigna Group (CI) Form 144 Filed on June 12 for Shares
On June 12, Cigna Group (CI) filed a Form 144, which indicates potential plans for the sale of shares. Form 144 is typically filed by affiliates or insiders to notify the SEC of a proposed sale of restricted or control securities. This filing can signal changes in ownership and may affect investor confidence. It’s important for stakeholders to monitor these filings as they can have implications for stock liquidity and future volatility.
Read More: Cigna Group (CI) Form 144 Filed on June 12 for Shares
Cigna (CI) Downgraded by Barclays, Price Target Cut to $304
On May 26, Barclays downgraded Cigna (CI) from Overweight to Equal Weight and reduced its price target from $310 to $304. The downgrade reflects concerns around Cigna's limited earnings upside potential due to its lower exposure to government insurance programs, alongside uncertainties regarding a pharmacy benefit manager transition. Additionally, Barclays highlighted risks related to commercial membership losses and potential job cuts related to AI. This situation contrasts with UBS's recent rating increase, raising Cigna's target to $400, indicating differing outlooks among analysts.
Read More: Cigna (CI) Downgraded by Barclays, Price Target Cut to $304
Cigna (CI) Q1 2026 Earnings Beat Expectations; Raises EPS Guidance
Cigna (CI) reported its Q1 2026 earnings, exceeding analyst expectations. The company raised its earnings per share (EPS) guidance for the year, indicating stronger financial performance. Cigna's revenue figures and additional growth metrics contributed to the positive outlook, which may influence investor sentiment and market performance. The upward revision of EPS guidance is particularly significant for forecasting future profitability and competitive positioning in the market.
Read More: Cigna (CI) Q1 2026 Earnings Beat Expectations; Raises EPS Guidance
CI&T Inc (CINT) Q4 2025 Revenue Increases 19.3% to $134 Million
CI&T Inc. (CINT) reported fourth quarter 2025 results showing a 19.3% year-over-year revenue increase to $134 million, marking five consecutive quarters of double-digit organic growth. The adjusted profit rose by 28.8% to $17 million, with diluted earnings per share increasing by 44.6% to $0.11. Canaccord Genuity raised the price target for CINT to $7 from $6 on March 12, reflecting growing confidence in the company's performance amid rising demand for enterprise AI solutions. For 2026, organic growth is projected at 14%, positioning CI&T as one of the fastest-growing firms in the technology sector.
Read More: CI&T Inc (CINT) Q4 2025 Revenue Increases 19.3% to $134 MillionMore Health Care stocks
Frequently asked questions
Is The Cigna Group in the S&P 500?
Yes. The Cigna Group trades as CI and is a member of the S&P 500. The index lists it in the Health Care sector.
What sector is CI in?
CI sits in the Health Care sector of the S&P 500.
Where can I find the latest CI news?
Right here. This page collects recent CI news and market analysis. Every story gets an AI summary and a bullish, bearish or neutral tag.
What is The Cigna Group's stock price?
CI last traded at about $302.30. Prices move all through the session, so this is the latest quote rather than a live one.
What is The Cigna Group's market cap?
CI is worth roughly $79.88B. Market cap is the share price times the number of shares outstanding.
What is CI's P/E ratio?
CI trades at a trailing P/E ratio of about 12.5. The ratio compares the share price with earnings per share over the past year.